PAHC · Phibro Animal Health Corp
United States · RS rating 51 · As of 2026-11-03
| Price | 37.65 USD |
|---|---|
| 1-day change | -2.8% |
| RS rating (overall / 1M / 3M / 12M) | 51 / 61 / 76 / 43 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 31 / 24 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +3.1% |
| Sales growth Q/Q | +2.8% |
| Distance from 52-week high | +36.8% |
| Market cap (USD) | $2.2B |